SCHEMBL4977191

SCHEMBL4977191

CCn1cnc2c(=O)n(-c3ccc(C#N)cc3)c(CC(C)C(F)(F)F)nc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 3/20 0.39
CTSK P43235 3/20 0.39
TRPV1 Q8NER1 1/20 0.35
CTSV O60911 1/20 0.35
CTSL P07711 1/20 0.35
CTSB P07858 1/20 0.35
CTSH P09668 1/20 0.35
CASP4 P49662 1/20 0.35
MMP14 P50281 1/20 0.35
CTSC P53634 1/20 0.35
BACE1 P56817 1/20 0.35
ADAM17 P78536 1/20 0.35
CTSZ Q9UBR2 1/20 0.35
KLK4 Q9Y5K2 1/20 0.35
PDE10A Q9Y233 1/20 0.34
CDK1 P06493 5/20 0.34
PRKCA P17252 2/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4428884 0.90 CTSS (0.38) CTSSCTSKTRPV1CTSVCTSL
SCHEMBL4430107 0.90 CTSS (0.37) CTSSCTSKTRPV1PDE10AALDH1A2
SCHEMBL4978987 0.89 SMN1; SMN2 (0.37) CTSSCTSKCDK1PDE4APDE4B
SCHEMBL4286790 0.88 CTSS (0.38) CTSSCTSKTRPV1CTSVCTSL
SCHEMBL4529554 0.88 DRD1 (0.41) CDK1PDE4APDE4BPDE4CPDE4D
SCHEMBL4978421 0.83 SRC (0.33) CTSSCTSKCDK1PDE4APDE4B
SCHEMBL4284241 0.80 PDE10A (0.37) CTSSCTSKTRPV1PDE10AALDH1A2
SCHEMBL4522018 0.80 CNR1 (0.46) DDR1NPC1ALDH1A1
SCHEMBL4520614 0.79 CNR1 (0.40) PDE4APDE4BPDE4CPDE4DDDR1
SCHEMBL4529223 0.79 HKDC1 (0.40) PDE10ACDK1PDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090845-A1 Haloalkyl-substituted pyrimidinone derivatives NEUROGEN CORPORATION (US) 2008-04-17 US claimed
US-20080090845-A1 Haloalkyl-substituted pyrimidinone derivatives NEUROGEN CORPORATION (US) 2008-04-17 US disclosed
US-20080090845-A1 Haloalkyl-substituted pyrimidinone derivatives NEUROGEN CORPORATION (US) 2008-04-17 US disclosed
US-20080090845-A1 Haloalkyl-substituted pyrimidinone derivatives NEUROGEN CORPORATION (US) 2008-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090845-A1 Haloalkyl-substituted pyrimidinone derivatives PIGS, GPR174, GPR17 CTSS 1447/4885CTSK 1812/4885TRPV1 159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.